Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Jun. 30, 2020
Current assets:    
Cash and cash equivalents $ 84,627,000 $ 55,112,000
Accounts receivable - trade 387,000 75,000
Accounts receivable - other 1,000  
Subscription receivable   5,549,000
Investments in debt securities 19,296,000  
Work in process 432,000 798,000
Prepaid expenses and other current assets 2,460,000 214,000
Total Current Assets 107,203,000 61,748,000
Note receivable and accrued interest 1,537,000  
Finance lease right-of-use assets, net of accumulated amortization 26,380,000 27,616,000
Fixed assets, net of accumulated depreciation 6,407,000 3,657,000
Intangible assets, net of accumulated amortization 1,146,000 1,144,000
Security deposits 24,000 24,000
Total Assets 142,697,000 94,189,000
Current liabilities:    
Accounts payable (related parties of $100 and $6 as of March 31, 2021 and June 30, 2020, respectively) 1,631,000 1,759,000
Accrued expenses (related party of $842 and $705 as of March 31, 2021 and June 30, 2020, respectively) 2,666,000 1,105,000
Finance lease obligation – current portion 318,000 301,000
Note payable – PPP Loan – current portion 566,000 261,000
Contract liabilities 886,000 1,810,000
Total Current Liabilities 6,067,000 5,236,000
Note payable – PPP Loan – net of current portion 34,000 339,000
Finance lease obligation – net of current portion 31,766,000 32,007,000
Total Liabilities 37,867,000 37,582,000
Commitments and Contingencies
iBio, Inc. Stockholders’ Equity:    
Common stock - $0.001 par value; 275,000,000 and 275,000,000 shares authorized at March 31, 2021 and June 30, 2020, respectively; 216,133,544 and 140,071,110 shares issued and outstanding as of March 31, 2021 and June 30, 2020, respectively 216,000 140,000
Additional paid-in capital 278,442,000 206,931,000
Accumulated other comprehensive loss (70,000) (33,000)
Accumulated deficit (173,743,000) (150,420,000)
Total iBio, Inc. Stockholders’ Equity 104,845,000 56,618,000
Noncontrolling interest (15,000) (11,000)
Total Equity 104,830,000 56,607,000
Total Liabilities and Equity $ 142,697,000 $ 94,189,000